| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $120.8M | -6.3% |
| R&D Expense | $37.4M | -75.3% |
| SG&A Expense | $26.3M | -34.2% |
| Operating Income | $35.9M | +143.0% |
| Interest Expense | $3.8M | -17.8% |
| Pre-tax Income | $32.7M | +138.3% |
| Income Tax | $31K | +358.3% |
| Net Income | $32.7M | +138.3% |
| EPS (Basic) | $2.61 | +122.9% |
| EPS (Diluted) | $2.57 | +122.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -66.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $1.3M | -15.5% |
| Inventory | $0 | -100.0% |
| Current Assets | $12.2M | -81.2% |
| Total Assets | $20.2M | -81.5% |
| Current Liabilities | $14.9M | -88.9% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.9M | +25.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $18.1M | +110.4% |
| Financing Cash Flow | $16.1M | -72.8% |
| Free Cash Flow | -$50.9M | +26.1% |
| $58.7M |
| -71.5% |
| Stockholders' Equity | -$38.5M | +60.4% |